Secondary Analysis and Integration of Existing Data Related to Chronic Orofacial Pain and Placebo Effects - Administrative Supplement
与慢性口面部疼痛和安慰剂效应相关的现有数据的二次分析和整合 - 行政补充
基本信息
- 批准号:10741330
- 负责人:
- 金额:$ 8.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2024-09-21
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationAdministrative SupplementAffectAgeAlgorithmsAreaBehavioralBiologicalBiological MarkersBloodBlood specimenCandidate Disease GeneCaringChronicClassificationClinicalComplexConsensusDataData AnalysesDopamineEndocannabinoidsEngineeringEnsureExpectancyFosteringFundingFutureGenesGeneticGenomicsGoalsHealthIndividualInterdisciplinary StudyKnowledgeLaboratoriesMachine LearningMedicineModelingMolecularNeural PathwaysNeuronsOpioidOrofacial PainPainPain intensityPain managementParticipantPathway interactionsPatientsPhenotypePlacebo EffectPlacebosPopulationPredictive FactorPreparationProcessProspective StudiesProteomicsPsychological FactorsPublishingQuality of lifeRecommendationReportingResearchResearch PrioritySamplingSerotoninSeveritiesSeverity of illnessSingle Nucleotide PolymorphismSystemTemporomandibular Joint DisordersTestingTherapeuticTwin Multiple BirthUnited States National Academy of SciencesValidationVariantVisualWorkanalogchronic painchronic pain patientchronic painful conditionclinical phenotypeclinically relevantcohortendophenotypegenetic variantgenome wide association studymachine learning modelmolecular markernon-opioid analgesicorofacialpain inhibitionpain reductionpain scorepain signalpillprecision medicinepsychologicpsychosocialrandomized, clinical trialsresponsesecondary analysissexsingle-cell RNA sequencingsociodemographicstraittranscriptometranscriptome sequencingtranscriptomic profilingtranscriptomics
项目摘要
This project in response to RFA-DE-22-011 aims to analyze existing data representing a subset of participants
with Temporomandibular disorders (TMD) who underwent in-depth clinical, behavioral, and psychological
phenotyping under R01 DE025946 (PI: Colloca, ending September 30, 2022). The proposed aims are
substantially different from the original R01-work exploring genetic variants associated with expectancy-induced
analgesia in chronic orofacial pain, psychological factors predicting placebo responders, and genes-related
neuronal changes in the prefrontal and limbic areas associated with expectancy-induced analgesia. Using
Dean’s Initiative Funds allocated to Dr. Colloca, we collected blood and extracted RNA-seq data from a subset
of 74 TMD participants. With the behavioral, psychological, clinical and now, transcriptomic data from this subset
of TMD participants, the central hypothesis is distinct Differently Expressed Genes (DEG) and pathways
associated with Endogenous Pain Modulation (EPM) characterize those TMD participants who show the highest
placebo effects. We will compare transcriptomic profiles associated with high versus low EPM via placebo
effects tested in TMD participants (AIM1) and we will predict high EPM integrating transcriptomic,
sociodemographic, clinical and psychological data (Exploratory Specific Aim 2) using machine learning
models. In order to identify transcriptomic profiles of high placebo responsiveness, TMD participants will be
divided into High Placebo Responders (HLR) and Low Placebo Responders (LPR) based on an average reported
pain score cut-off of 30 on a visual analogue scale (VAS) anchored from zero=no pain to 100=maximum
imaginable pain. Based on our prior published results, informative preliminary results, and DEG power
calculation, we expect enough power to identify key DEG associations in HPR compared to those TMD who do
not respond and/or have lower placebo responses while controlling for sex, age and pain severity. Importantly,
unbiased enrichment analyses will be conducted to identify transcriptomic processes associated with EPM.
Machine learning approaches (e.g., generalized boosted models) will allow us to integrate sociodemographic,
clinical and psychological with transcriptomic markers to further characterize HPR in TMD participants. Our team
is strong with complementary expertise, ensuring that this research will provide integrative models towards step-
by-step discoveries of molecular mechanisms characterizing those who show the largest activation of EPM via
placebo effects. This is the first project to use transcriptomic profiling and machine learning models to predict
EPM in an understudied TMD population. Findings will have high clinical relevance and will inform more
extensive studies generating knowledge that will be critical to guide future steps towards integrative and
translational precision medicine.
响应RFA-DE-22-011的本项目旨在分析代表参与者子集的现有数据
颞下颌关节紊乱病(TMD)患者接受了深入的临床、行为和心理治疗,
根据R 01 DE 025946进行表型分型(PI:Colloca,2022年9月30日结束)。建议的目标是
实质上不同于原始R 01-探索与预期诱导的遗传变异相关的工作,
慢性口面疼痛的镇痛,心理因素预测安慰剂反应,基因相关
前额叶和边缘区的神经元变化与预期诱导的镇痛有关。使用
在分配给Colloca博士的Dean's Initiative Funds中,我们收集了血液并从一个子集中提取了RNA-seq数据
74名TMD参与者。从这个子集的行为,心理,临床和现在,转录组数据
在TMD参与者中,中心假设是不同的重复表达基因(DEG)和途径
与内源性疼痛调节(Endogenous Pain Modulation,ESTA)相关的特征是那些表现出最高的
安慰剂效应我们将通过安慰剂比较与高与低剂量相关的转录组学特征
在TMD参与者(AIM 1)中测试的效果,我们将预测高整合转录组,
使用机器学习的社会人口统计学、临床和心理数据(探索性特定目标2)
模型为了确定高安慰剂反应性的转录组学特征,TMD参与者将被
根据报告的平均值分为安慰剂高应答者(RPR)和安慰剂低应答者(LPR)
视觉模拟量表(VAS)上的疼痛评分临界值为30,从0 =无疼痛锚定到100=最大疼痛
想象的痛苦。根据我们先前发表的结果、信息丰富的初步结果和DEG功效,
计算,我们希望有足够的权力,以确定关键的DEG协会在HPR相比,那些TMD谁做
在控制性别、年龄和疼痛严重程度的同时,没有反应和/或具有较低的安慰剂反应。重要的是,
将进行无偏富集分析以鉴定与转录相关的转录组学过程。
机器学习方法(例如,广义提升模型)将允许我们整合社会人口统计学,
临床和心理与转录组学标记,以进一步表征HPR在TMD参与者。我们的团队
具有互补的专业知识,确保这项研究将提供综合模型,
逐步发现分子机制,这些机制表征了那些通过以下方式表现出最大程度激活EPM的人
安慰剂效应这是第一个使用转录组学分析和机器学习模型来预测
在一个未被充分研究的TMD人群中。研究结果将具有很高的临床相关性,并将提供更多信息。
广泛的研究产生的知识,将是至关重要的,以指导未来的步骤,
转化精准医学
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
How negative and positive constructs and comorbid conditions contribute to disability in chronic orofacial pain.
消极和积极的结构以及合并症如何导致慢性口面部疼痛的残疾。
- DOI:10.1002/ejp.2042
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Thomas,Sharon;Wang,Yang;Cundiff-O'Sullivan,Rachel;Massalee,Rachel;Colloca,Luana
- 通讯作者:Colloca,Luana
Clinical Phenotypes Supporting the Relationship Between Sleep Disturbance and Impairment of Placebo Effects.
支持睡眠障碍与安慰剂效应受损之间关系的临床表型。
- DOI:10.1016/j.jpain.2023.10.013
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Wang,Yang;Varghese,Jeril;Muhammed,Salim;Lavigne,Gilles;Finan,Patrick;Colloca,Luana
- 通讯作者:Colloca,Luana
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luana Colloca其他文献
Luana Colloca的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luana Colloca', 18)}}的其他基金
Secondary Analysis and Integration of Existing Data Related to Chronic Orofacial Pain and Placebo Effects
与慢性口面部疼痛和安慰剂效应相关的现有数据的二次分析和整合
- 批准号:
10597861 - 财政年份:2022
- 资助金额:
$ 8.78万 - 项目类别:
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
沉浸式虚拟现实治疗慢性疼痛的神经机制
- 批准号:
10617854 - 财政年份:2021
- 资助金额:
$ 8.78万 - 项目类别:
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
沉浸式虚拟现实治疗慢性疼痛的神经机制
- 批准号:
10314729 - 财政年份:2021
- 资助金额:
$ 8.78万 - 项目类别:
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
沉浸式虚拟现实治疗慢性疼痛的神经机制
- 批准号:
10455010 - 财政年份:2021
- 资助金额:
$ 8.78万 - 项目类别:
Neural correlates of hypoalgesia driven by observation
观察驱动的痛觉减退的神经相关性
- 批准号:
10452769 - 财政年份:2019
- 资助金额:
$ 8.78万 - 项目类别:
Neural correlates of hypoalgesia driven by observation
观察驱动的痛觉减退的神经相关性
- 批准号:
10212245 - 财政年份:2019
- 资助金额:
$ 8.78万 - 项目类别:
Neural correlates of hypoalgesia driven by observation
观察驱动的痛觉减退的神经相关性
- 批准号:
10673015 - 财政年份:2019
- 资助金额:
$ 8.78万 - 项目类别:
Chronic orofacial pain: genetics, cognitive-emotional factors, and endogenous modulatory systems
慢性口面部疼痛:遗传、认知情绪因素和内源性调节系统
- 批准号:
9265070 - 财政年份:2016
- 资助金额:
$ 8.78万 - 项目类别:
Chronic orofacial pain: genetics, cognitive-emotional factors, and endogenous modulatory systems
慢性口面部疼痛:遗传、认知情绪因素和内源性调节系统
- 批准号:
9098079 - 财政年份:2016
- 资助金额:
$ 8.78万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别:
Sedentary behavior, physical activity, and 24-hour behavior in pregnancy and offspring health: the Pregnancy 24/7 Offspring Study Administrative Supplement
久坐行为、体力活动和 24 小时行为对怀孕和后代健康的影响:怀孕 24/7 后代研究行政补充
- 批准号:
10893074 - 财政年份:2023
- 资助金额:
$ 8.78万 - 项目类别: